ATYR Operating Cash Flow (Statement)

Atyr Pharma Inc · Operating Cash Flow (Statement)

ATYR logo

ATYR Operating Cash Flow (Statement)

Latest reported-$54.54M
ATYR TTM Cash from Operations (-$22.82M → -$54.54M)
High-resolution chart · PNG

ATYR operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atyr Pharma Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-54,540,000
-59,083,000
-61,986,000
-62,922,000
-55,604,000
-62,159,000
-69,119,000
-67,049,000
-63,450,000
-55,011,000
-33,221,000
-32,528,000
-35,250,000
-32,357,000
-41,886,000
-39,603,000
-38,792,000
-37,367,000
-33,075,000
-30,390,000
-24,475,000
-23,186,000
-15,301,000
-14,816,000
-13,514,000
-11,932,000
-20,013,000
-19,936,000
-22,143,000
-26,509,000
-31,063,000
-36,530,000
-38,964,000
-39,053,000
-42,364,000
-43,753,000
-49,546,000
-54,258,000
-52,861,000
-51,001,000
-45,781,000
-43,002,000
-36,797,000
-32,763,000
-29,074,000
-22,765,000
-22,824,000
-21,334,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.